RHINOSINUSITIS : Natural product against inflammation affecting both the sinuses and the nasal mucosa.
NESOSPRAY from Vitrobio is an innovative nasal spray designed for the treatment of rhinosinusitis, rhinitis, and nasal congestion in adults. It works by creating a filmogenic liquid bandage on the nasal mucosal surface, providing hydration, cleansing, and reducing contaminants and pro-inflammatory proteins through osmotic action. Clinical trials have shown a 30% reduction in nasal congestion within 30 minutes and a 59% reduction in all rhinosinusitis symptoms within just 1 day of treatment.
Vitrobio presents NESOSPRAY, an innovative solution specifically designed for the treatment of rhinosinusitis, rhinitis, and nasal congestion in adults. This product is a nasal spray in a convenient 15 ml format, designed for easy application and optimal delivery of the active components.
Targeted Proteins and Actions
Protective Barrier Effect: NESOSPRAY works by creating a filmogenic liquid bandage on the nasal mucosal surface. This protective barrier shields the nasal mucosa from further irritation or infection, providing an immediate layer of defense.
Osmotic Action: The spray also exerts an osmotic action, which attracts fluids towards the exterior, helping to massively unblock congested sinuses. This osmotic action also cleanses the nasal mucosa by effectively drawing out contaminants, debris, and pro-inflammatory proteins such as cytokines and interleukins. This dual action of unblocking and cleansing provides immediate relief and creates a clean environment conducive to healing.
Cellular Repair and Growth Effect: With the nasal mucosa now in a clean and protected state, the healing process can effectively begin. The spray promotes cell growth and repair, allowing the nasal mucosa to regenerate and regain its integrity. This restoration of the nasal mucosa is crucial for long-term relief from rhinosinusitis, rhinitis, and nasal congestion.
Clinical Trials and Results
The effectiveness of NESOSPRAY has been evaluated in a randomized, double-blind clinical trial against a placebo, conducted over 3 weeks with 113 patients. The trial included patients with rhinosinusitis, encompassing all symptoms related to this condition.
The main results of the trial were highly promising. There was a 30% reduction in nasal congestion within 30 minutes of application. Furthermore, there was a 59% reduction in all rhinosinusitis symptoms within just 1 day of treatment.
In conclusion, NESOSPRAY represents a significant advancement in the treatment of rhinosinusitis, rhinitis, and nasal congestion in adults. Its unique mechanism of action, combined with its ease of use and rapid results, make it a promising addition to the therapeutic options available for these common conditions.
Understanding Rhinosinusitis, Rhinitis, and Nasal Congestion in Adults
Rhinosinusitis, rhinitis, and nasal congestion are common health issues that can significantly affect adults’ comfort and quality of life. These conditions are characterized by inflammation and swelling in the nose and sinuses, leading to symptoms such as a runny or stuffy nose, sneezing, and facial pain or pressure.
Causes and Symptoms of Rhinosinusitis, Rhinitis, and Nasal Congestion
These conditions can be caused by various factors, including viral infections (like the common cold or flu), allergies, and environmental irritants. In adults, these conditions can also be exacerbated by factors such as exposure to secondhand smoke, changes in weather, or underlying health conditions like asthma.
The symptoms of rhinosinusitis, rhinitis, and nasal congestion can be particularly bothersome for adults, affecting their sleep, productivity, and overall quality of life. These symptoms can also lead to other complications, such as sinusitis or ear infections, if not properly treated.
Treatment for Rhinosinusitis, Rhinitis, and Nasal Congestion in Adults
Treatment for these conditions typically involves managing the symptoms and addressing the underlying cause. This can include the use of over-the-counter remedies, prescription medications, and in some cases, lifestyle changes or procedures. It’s important for individuals to consult with a healthcare provider to determine the best course of treatment for their condition.
Prevention of Rhinosinusitis, Rhinitis, and Nasal Congestion in Adults
Prevention strategies include regular hand washing, avoiding known allergens, and maintaining a healthy indoor environment. Regular check-ups with a healthcare provider can also help detect and manage these conditions early.
Rhinosinusitis, rhinitis, and nasal congestion can significantly impact an adult’s wellbeing. Understanding these conditions, their causes, symptoms, and treatment options can help individuals seek timely medical care and manage their symptoms effectively. With the right treatment, such as NESOSPRAY, adults can find relief from these common conditions and enjoy a better quality of life.
CLAIMS IN LINE WITH THE NEW REGULATION
- Mechanical mode of action
- Instant osmotic action
- Clears, decongests and cleanses the sinuses
- Dual action: Relieves and protects
- Reduces contaminants on the nasal surface
- Reduces nasal congestion, sinus pain (<30min)
- Reduce all the rhinosinusitis symptoms
- Reduces the need for antibiotics
- No drowsiness . No habituation effect
- Fast action
RHINOSINUSITIS Randomized, double-blind clinical trial
Title : Preventing rhinosinusitis by reducing nasal surface contaminants & restoring nasal mucosa integrity: Clinical efficacy of a new generation of polymeric osmotic treatment- RHINOSINUSITIS
Journal : American Journal of Pharmatech Research (2013)
Patients: N=113 | Test product = 62 ; Comparator = 51
Duration : 3 weeks
Inclusion : Patients with rhinosinusitis including all symptoms
- 30 % reduction in nasal congestion within 30 min
- 40 % reduction in nasal congestion within 1 days
All RHINOSINUSITIS SYMPTOMS
- 59% reduction in all the symptoms within 1 day
- 58% reduction in sinus pain within 1 day
- Reduction in the need for antibiotics
|Indication||Filmogen liquid bandage for the treatment of rhinosinusitis, rhinitis and nasal congestion.|
|Composition||Filmogenic glycerol, water, association of Vaccinium macrocarpon, Camellia sinensis, Vaccinium myrtillus and Sambucus nigra.|
|Presentation||Nasal spray 15ml|
|Class||MDD Class I | MDR Class IIa|
|Direction||Apply 2 sprays in each nostril, 2-3 times a day|
|Precautions||For topical use only (nasal cavity). Keep out of reach and sight of children.|
|Storage conditions||Below 25°C|
|Legal manufacturer||VITROBIO (France)|